Riskpilot← Back to searchSign inGet full accessFarndon Oy
OYDissolvedY-tunnus 3125301-9Hukankatu 1-EMedical specialists activities · NACE 8622Est. 20201 employees
Revenue 2025
EUR 141K
0% vs 2024
EBITDA margin
-0.8%
-153% vs 2024
Equity ratio
94.2%
Financial strength
Net profit 2025
EUR 3K
+98% vs 2024
| Revenue | EUR 141K | +0% |
| EBITDA | EUR -1K | -153% |
| Net profit | EUR 3K | +98% |
| Total assets | EUR 68K | -3% |
| Equity | EUR 64K | -3% |
| Employees | 1 | — |
Legal name
Farndon Oy
Y-tunnus number
3125301-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
10. maaliskuuta 2020
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on yleis- ja erikoislääkärin vastaanotto sekä esteettiset toimenpiteet ja hoidot. Toimialana voi olla myös koulutus ja konsultointi sekä kaikki muu laillinen liiketoiminta. Yhtiö voi omistaa ja hallita kiinteistöjä, osakkeita ja arvopapereita sekä vuokrata niitä ja käydä niillä kauppaa.
Address
Hukankatu 1-E
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 144 | 120 | 149 | 140 | 141 |
| Staff expenses | −78 | −96 | −112 | −113 | −118 |
| EBITDA | 51 | −2 | 16 | 2 | −1 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 51 | −2 | 16 | 2 | −1 |
| Net financials | −0 | −3 | −0 | −0 | 5 |
| Profit before tax | 51 | −5 | 16 | 2 | 4 |
| Tax | 10 | −0 | 2 | 0 | 1 |
| Net profit | 41 | −5 | 14 | 2 | 3 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 82 | 68 | 7 287 | 70 | 68 |
| Equity | 72 | 61 | 6 970 | 66 | 64 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 10 | 7 | 316 | 4 | 4 |
| Total debt | 10 | 7 | 316 | 4 | 4 |
EBITDA margin
-0.8%
This company
15.8%
Market median
-105% vs market
20212025
Equity ratio
94.2%
This company
38.2%
Market median
+147% vs market
20212025
Return on equity
5.0%
This company
18.4%
Market median
-73% vs market
20212025
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20212025
Asset turnover
2.08×
This company
1.12×
Market median
+86% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
IK Deputy Member | Deputy Member | 2020 |
AK Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Farndon Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inga Kusrati | Deputy Member | 0 companies |
| Alan Kusrati | Chief Executive Officer | 0 companies |